COMMUNIQUÉS West-GlobeNewswire

Presentation of the Congress of the European Academy of Allergy and Clinical Immunology (EAACI) to be held in Valencia from May 31 to June 3
30/05/2024
VALENCIA, Spain, May 30, 2024 (GLOBE NEWSWIRE) -- Under the theme "Revolutionizing Patient Care through the Power of Data Science," the congress will highlight the crucial role of Allergy and Clinical Immunology in [...]
Vision Sensing Acquisition Corp. Announces Intention to Extend the Period to Consummate Its Initial Business Combination to July 3, 2024
30/05/2024
NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “ Company ”), a special purpose acquisition company, announced today that it has notified Continental Stock [...]
Privia Health to Participate in the William Blair Growth Stock Conference
30/05/2024
ARLINGTON, Va., May 30, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that its management team plans to present at the 44 th Annual William Blair Growth Stock Conference on Wednesday [...]
AVITA Medical Announces FDA Approval of RECELL GO
30/05/2024
VALENCIA, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin [...]
Biomea Fusion Announces Completion of Enrollment of First 3 Arms in Phase 2 Expansion Cohorts of COVALENT-111 Study for BMF-219 in Type 2 Diabetes
30/05/2024
BMF-219 is an investigational novel covalent menin inhibitor developed to regenerate insulin-producing beta cells REDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a [...]
Press Release: Sanofi completes acquisition of Inhibrx, Inc.
30/05/2024
Sanofi completes acquisition of Inhibrx, Inc. Paris, May 30, 2024. Sanofi announced today the completion of its acquisition of Inhibrx, Inc . (“Inhibrx”). The acquisition adds SAR447537 (formerly INBRX-101) to Sanofi’s [...]
Communiqué de presse : Sanofi finalise l’acquisition d’Inhibrx, Inc.
30/05/2024
Sanofi finalise l’acquisition d’Inhibrx, Inc. Paris, le 30 mai 2024. Sanofi annonce aujourd’hui la finalisation de son acquisition d’Inhibrx, Inc . (« Inhibrx »). Cette opération ajoute le SAR447537 (anciennement INBRX- [...]
Philips celebrates 1.9m liters of helium saved as it marks 1,111 helium-free MRI operations installs, expanding care to more patients in more locations
30/05/2024
May 30, 2024 First to provide helium-free operations in 2018, Philips marks milestone during installation in Puerto Rico Amsterdam, the Netherlands and Bayamón, Puerto Rico – Royal Philips (NYSE: PHG, AEX: PHIA), a [...]
Disc Medicine to Participate in the Jefferies Global Healthcare Conference
30/05/2024
WATERTOWN, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for [...]
Clinical Data Published at ASCO Support the Potential of VIVUS’ PANCREAZE® to Stabilize Weight and Improve Gastrointestinal Outputs in Patients with Pancreatic Cancer
30/05/2024
CAMPBELL, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with [...]
Coherus Management to Present at the 2024 Jefferies Global Healthcare Conference
30/05/2024
REDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) today announced that senior management will present at the 2024 Jefferies Global Healthcare Conference on Thursday [...]
Revolutionizing Oncology Care: AI-Powered Ultrasound Device Enhances Cardiac Monitoring for Chemotherapy Patients
30/05/2024
REDMOND, Wash., May 30, 2024 (GLOBE NEWSWIRE) -- A recent study published in the European Heart Journal highlights the significant enhancements that the Kosmos ultrasound system, developed by EchoNous, brings to cardiac [...]
Verana Health Announces Launch of Qdata® Uveitic Macular Edema Module
30/05/2024
Expansive, high-quality real-world dataset of more than 152,000 de-identified patients utilizes electronic health record data to confirm the diagnosis and better understand the outcomes of patients with uveitic macular [...]
New AAMI Guidance on Combination Products and FDA CGMPs
30/05/2024
Arlington, Virginia, May 30, 2024 (GLOBE NEWSWIRE) -- As the breadth and scope of combination products around the world continues to ramp up, are U.S. manufacturers equipped with the best design plans possible? A brand- [...]
Johnson & Johnson MedTech gathers multi-disciplinary expert group to optimise lung cancer care and dialogue between patients and their healthcare team
30/05/2024
A recent European survey revealed that 80 percent of thoracic surgeons declared to follow the Enhanced Recovery After Surgery (ERAS) protocol, focussed on improving peri-operative lung cancer care, 1 simultaneously, [...]
Telomir Pharmaceuticals Announces Two Pivotal Milestones for Lead Product Candidate Telomir-1
30/05/2024
Commences the study, The Safety of Telomir-1 when Administered Orally to Geriatric Laboratory Beagle Dogs for 63 Consecutive Days study to evaluate the safety of Telomir-1 on geriatric canines Began geriatric canine [...]
Ascendis to Spotlight Latest Updates for TransCon™ Rare Endocrinology Disease Portfolio at ENDO 2024
30/05/2024
COPENHAGEN, Denmark, May 30, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that it will host informational booths, events, and presentations showcasing use of its innovative TransCon [...]
Day One Announces Sale of Priority Review Voucher for $108 Million
30/05/2024
BRISBANE, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a commercial-stage biopharmaceutical company dedicated to developing and commercializing [...]
Wave Life Sciences to Present at 2024 Jefferies Global Healthcare Conference
30/05/2024
CAMBRIDGE, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today [...]

Pages